Insmed Inc Investor and Analyst Event Transcript
Good morning, everyone, and welcome to The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More.
For those who may not yet know me, my name is Bryan Dunn, and I have the privilege of leading Investor Relations here at Insmed. And given that the word "Future" is in the name of this event, it will come as no surprise to any of you that we will be making forward-looking statements during today's presentation.
So before we begin, on the slide behind me, you will find additional information about risks and uncertainties associated with those statements.
With that, we will begin the presentation with this short video.
(presentation)
"Count us in". The idea of "Count us in" comes from a story about a young man who visited Insmed almost 10 years ago with his mom. The whole company numbered about 30 employees at that time, and our inhaled antibiotic was being considered for treating patients with cystic fibrosis. This
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |